OB | IBN | Total new bone | β-TCP HA | |
---|---|---|---|---|
Bone walls plasma | 25.1 ± 7.5 (20.1; 30.0) | 22.0 ± 6.8 (17.5; 26.5) | 47.1 ± 12.4 (39.0; 55.1) | 20.1 ± 10.1 (13.5; 26.8) |
Bone walls control | 24.4 ± 8.5 (18.9; 29.9) | 17.5 ± 8.7 (11.8; 23.2) | 41.9 ± 12.5 (33.7; 50.1) | 25.0 ± 11.9 (17.2; 32.8) |
p | 0.859 | 0.051 | 0.214 | 0.051 |
Central plasma | 11.8 ± 11.6 (4.2; 19.4) | 21.4 ± 11.2 (14.1; 28.8) | 33.2 ± 19.6 (20.4; 46.0) | 29.4 ± 18.6 (17.2; 41.6) |
Central control | 5.9 ± 6.5 (1.6; 10.1) | 17.9 ± 13.3 (9.2; 26.6) | 23.8 ± 19.1 (11.3; 36.2) | 38.9 ± 15.0 (29.1; 48.7) |
p | 0.161 | 0.362 | 0.208 | 0.214 |
Sub-mucosa plasma | 12.2 ± 11.7 (4.5; 19.8) | 12.4 ± 11.8 (4.7; 20.1) | 24.6 ± 20.5 (11.2; 38.0) | 38.1 ± 20.0 (25.0; 51.2) |
Sub-mucosa control | 8.5 ± 11.9 (0.7; 16.3) | 12.8 ± 11.7 (5.1; 20.4) | 21.2 ± 20.8 (7.7; 34.8) | 40.9 ± 21.4 (26.9; 54.9) |
p | 0.515 | 0.678 | 0.594 | 0.678 |
Close-to-window plasma | 12.9 ± 11.9 (5.1; 20.7) | 15.9 ± 8.5 (10.4; 21.5) | 28.8 ± 17.6 (17.3; 40.3) | 29.4 ± 12.2 (21.4; 37.4) |
Close-to-window control | 13.4 ± 8.4 (7.9; 18.9) | 14.5 ± 9.7 (8.1; 20.8) | 27.9 ± 15.9 (17.5; 38.3) | 29.8 ± 16.4 (19.1; 40.5) |
p | 0.767 | 0.594 | 0.813 | 0.906 |